{"id":"tp-53256","type":"article-newspaper","title":"Bicara Reports Substantial Enrollment in FORTIFI-HN01 Cancer Trial","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/53256","datePublished":"2026-11-10T17:57:38.000Z","dateModified":"2026-11-10T17:57:38.000Z","language":"en","abstract":"Bicara expects topline results from an interim analysis in mid-2027 and says its $442.3 million in cash, cash equivalents and marketable securities can fund operations into the first half of 2029.","section":"Business","references":[]}